Jim has spent his entire career in the Life Science and Biotech field. As CEO for various life science companies he has been responsible for raising over $400 Million of capital and delivering exit market caps of over $8.6 Billion.
Jim’s early career spanned 21 Years in Diagnostics at Abbott Laboratories both domestically and internationally, primarily in Senior Marketing Positions of Transfusion Medicine; Hepatitis/AIDS Products including First FDA Approved AIDS Test; Chemical; and Agricultural Products.
Jim spent the following 25 Years transitioning into Entrepreneurial and Transactional Leadership. He was
• CEO of Ventana Medical Systems; Jim was responsible for the turnaround of the company and ultimate IPO in July 1996 and Secondary Stock Offering; VMSI Ultimately Sold to Roche in 2008 for $ 3.8 Billion
• CEO of Centocor Diagnostics sold to Fujirebio total proceeds $ 53 Million
• CEO of Minntech, Inc. sold to Cantel Medical total proceeds $ 70 Million (Current Cantel Market Cap $ 4.8 Billion)
• COO of Bioarray Solutions, LLC. Series C $ 20 Million and sold to Immucor, Inc. Total proceeds $ 120 Million
Jim continues to be an Independent Consultant to both Public and Venture Backed Companies.